The University of Newcastle

Ecofibre USA Inc.

Ecofibre Limited

Pradeep Singh Tanwar

Alexandra M Capano

Alex Nance

Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD wherein preferably the cannabis extract is administered via a mucosal formulation.

Methods of treating ovarian cancer with hemp extract

A method for treating a noncancerous gynecological disorder comprising: administering to a patient an effective amount of composition comprising aextract comprising cannabidiol (CBD) wherein the composition is preferably administered in a mucosal form, such as intravaginally.

Methods of treating endometriosis and other noncancer gynecological disorders with hemp extract

Compositions and methods of use of treatment of one or more of ovarian cancer, endometrial cancer, head and neck cancer, noncancerous gynecological disorders, and estrogen sensitive cancers, the composition comprising an effective amount of a cannabinoid and a flavonoid wherein the method comprises administering to a patient in need thereof an effective amount of the composition and optionally administering the composition concomitantly with a chemotherapeutic agent.

Stabilized compositions comprising cannabidiol

A method for treating endometrial cancer comprising: administering to a patient aextract (CE) wherein theextract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE.

Methods of treating endometrial cancer using hemp extract

Disclosed herein are methods for treating estrogen sensitive disease, specifically toward endometrial cancers, and compositions used to treat the estrogen sensitive disease. Methods for treating estrogen sensitive diseases comprise administering to a patient an effective amount of aextract in the presence of an elevated level of estrogen wherein the estrogen is endogenous estrogen or further comprises exogenous estrogen and wherein the methods may further comprise the addition of a chemotherapeutic agent.

Methods of treating estrogen sensitive diseases with cannabis extract

Provided herein are methods for detecting an estrogen-induced cancer in a subject, for identifying a subject at risk of developing an estrogen-induced cancer and for determining or predicting prognosis for a subject with an estrogen-induced cancer. The methods of the disclosure comprise determining the level of expression of ALPPL2 in a biological sample, typically a blood sample, obtained from a subject.

Diagnostic and prognostic methods for estrogen-induced cancers

A method for treating a noncancerous gynecological disorder comprising: administering to a patient and effective amount of composition comprising aextract comprising cannabidiol (CBD) wherein the composition is preferably administered in a mucosal form, such as intravaginally.

A method for treating endometrial cancer comprising: administering to a patient a cannabis extract (CE) wherein the cannabis extract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE.

A method for treating a noncancerous gynecological disorder comprising: administering to a patient and effective amount of composition comprising a cannabis extract comprising cannabidiol (CBD), wherein the composition is preferably administered in a mucosal form, such as intravaginally.

Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract

Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD, wherein preferably, the cannabis extract is administered via a mucosal formulation.

Growing community of inventors

Fletcher, Australia

Pradeep Singh Tanwar